Merck Wins US Approval for a New Diabetes Drug
New York Times - Oct 18, 2006 By ALEX BERENSON. Federal drug regulators yesterday approved a new diabetes medicine from Merck that is expected to become a blockbuster treatment used by ...
|
|
AstraZeneca drops new diabetes drug
Independent - May 5, 2006 By Julia Kollewe, Pharmaceuticals Correspondent. AstraZeneca, already struggling to fill its truncatedpipeline of new medicines, suffered a fresh setback ...
|
|
|
Trials of new diabetes drug planned
The Australian - Jun 23, 2006 Article from: Australian AP. A MELBOURNE company is expected to begin human trials of a new oral drug to treat type 2 diabetes within six months. ...
|
|
|
|
FDA approves Merck's new diabetes drug
Bizjournals.com - Oct 17, 2006 Januvia works by enhancing a natural body system to significantly lower elevated blood sugar levels. The Merck (NYSE:MRK) drug was approved as monotherapy ...
|
|
|
EU approval for new diabetes drug
Hays Pharma - Nov 22, 2006 Byetta (exenatide) has been approved to treat type two diabetes by the European Commission, according to Eli Lilly and Amlin Pharmaceuticals. ...
|
|
|